Summary:
A study testing an investigational medication for adult patients diagnosed with migraines who have had an inadequate response to 2-4 prior preventive migraine medications such as atenolol, metoprolol, propranolol, topirimate, valproic acid, amitriptyline or botox injections. The study is 12 months long and consists of 9 study visits to the site. Study drug is a subcutaneous injection every 4 weeks completed during the site visits by Study personnel.
Qualified Participants Must:
• Be diagnosed with Migraines before age 50
•
Be ages 18-70 years old
•
Have had an inadequate response to 2-4 prior preventive migraine medications such as atenolol, metoprolol, propranolol, topirimate, valproic acid, amitriptyline or botox injections
Qualified Participants May Receive:
Compensation for time and travel.